Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 846.75 INR
Change Today -3.25 / -0.38%
Volume 11.2K
SEQ On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

sequent scientific ltd (SEQ) Snapshot

Open
845.00
Previous Close
850.00
Day High
849.50
Day Low
835.00
52 Week High
08/28/15 - 889.00
52 Week Low
11/24/14 - 391.15
Market Cap
34.9B
Average Volume 10 Days
23.1K
EPS TTM
-3.75
Shares Outstanding
41.3M
EX-Date
09/16/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SEQUENT SCIENTIFIC LTD (SEQ)

Related News

No related news articles were found.

sequent scientific ltd (SEQ) Related Businessweek News

No Related Businessweek News Found

sequent scientific ltd (SEQ) Details

SeQuent Scientific Limited operates as an integrated pharmaceutical company in India and internationally. It produces human and animal health APIs. The company’s human APIs portfolio covers anti-malarial, anthelmintic, anti-infective, antiviral, CNS, and dermatology therapeutic segments; and animal health APIs covers anthelmintic, anti-protozoal, nutraceutical, nonsteroidal anti-inflammatory drug, anti-infective, dermatology, and other therapeutic segments. It also provides contract research services comprising analytical and bio analytical services to support the API, pharmaceutical, personal care, institutional, and nutraceutical companies. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to SeQuent Scientific Limited in October 2009. SeQuent Scientific Limited was incorporated in 1985 and is based in Bengaluru, India.

1,088 Employees
Last Reported Date: 05/19/15
Founded in 1985

sequent scientific ltd (SEQ) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sequent scientific ltd (SEQ) Key Developments

Sequent Scientific Ltd Appoints Narendra Mairpady as Independent Director (Additional Director)

Sequent Scientific Ltd. announced that Mr. Narendra Mairpady has been appointed as an Independent Director (Additional Director) of the company with effective from August 01, 2015. Mr. Mairpady is not related to any other Director in the company.

Sequent Scientific Ltd. Reports Unaudited Standalone and Consolidated Earnings Results for the First Quarter Ended June 30, 2015

Sequent Scientific Ltd. reported unaudited standalone and consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, on standalone basis, the company reported total income from operations (net) of INR 1,081.810 million compared to INR 1,130.270 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 78.160 million compared to loss from operations before other income, finance costs and exceptional items of INR 10.230 million a year ago. Profit from ordinary activates before tax was INR 38.080 million compared to loss from ordinary activates before tax of INR 124.850 million a year ago. Net profit for the period was INR 38.080 million or INR 0.98 per diluted share before and after extraordinary items (not annualized) compared to net loss of INR 124.850 million or INR 4.57 per basic and diluted share before and after extraordinary items (not annualized) a year ago. For the quarter, on consolidated basis, the company reported total income from operations (net) of INR 1,484.498 million compared to INR 1,127.499 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 93.068 million compared to loss from operations before other income, finance costs and exceptional items of INR 7.541 million a year ago. Profit from ordinary activates before tax was INR 14.338 million compared to loss from ordinary activates before tax of INR 101.311 million a year ago. Net profit for the period was INR 4.968 million or INR 0.19 per diluted share before and after extraordinary items (not annualized) compared to INR 110.041 million or INR 4.17 per basic and diluted share before and after extraordinary items (not annualized) a year ago. EBITDA WAS INR 188 million compared to INR 74 million a year ago.

Sequent Scientific Ltd. to Report Q1, 2016 Results on Jul 30, 2015

Sequent Scientific Ltd. announced that they will report Q1, 2016 results on Jul 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SEQ:IN 846.75 INR -3.25

SEQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SEQ.
View Industry Companies
 

Industry Analysis

SEQ

Industry Average

Valuation SEQ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.0x
Price/Book 27.3x
Price/Cash Flow 99.3x
TEV/Sales 5.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEQUENT SCIENTIFIC LTD, please visit www.sequent.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.